Assessing the risk of venous thromboembolism and bleeding among patients with myeloproliferative neoplasms undergoing total knee and hip arthroplasty.

Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests Jeffrey Zwicker reports a relationship with Calyx that includes: consulting or advisory. Jeffrey Zwicker reports a relationship with CSL Behring LLC that includes: consulting or advisory. Jeffrey Zwicker reports a relationship with Sanofi that includes: consulting or advisory. Jeffrey Zwicker reports a relationship with Quercegen that includes: funding grants. Jeffrey Zwicker reports a relationship with Incyte Corporation that includes: funding grants. Rushad Patell reports a relationship with Merck Research Laboratories that includes: consulting or advisory. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.